Screening and comorbidity of clinical levels of fear of cancer recurrence
The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Purpose The prevalence of clinical levels of fear of cancer recurrence (FCR) in cancer survivors is unknown, which may be partly explained by the lack of an assessment method that would make it possible to distinguish between normal and clinical levels of FCR. Moreover, despite the apparent overlap between FCR and manifestations of some psychiatric disorders, no study has yet evaluated the comorbidity of clinical levels of FCR. The goals of this study were to assess the capacity of the Fear of Cancer Recurrence Inventory severity subscale, to consider a shorter form of the FCRI (FCRI-SF), to screen for clinical levels of FCR, and to assess its psychiatric comorbidity.Methods Sixty French-Canadian cancer survivors (73% of those eligible) who had been treated within the past 4 years for localized breast, prostate, lung, or colorectal cancer were randomly selected. Participants were administered a clinical interview assessing FCR, the Structured Clinical Interview for DSM-IV, and self-report scales.Results A cutoff score of 13 or higher on the FCRI-SF was associated with optimal sensitivity (88%) and specificity (75%) rates for the screening of clinical levels of FCR. Cancer survivors with clinical levels of FCR were significantly more likely to meet the criteria for a current psychiatric disorder (60%) than patients with nonclinical levels (29%). Anxiety disorders tended to be the most common comorbid disorders.Conclusions/implications for cancer survivors The FCRI-SF allows rapid and effective screening of clinical levels of FCR, a condition associated with significant psychiatric comorbidity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Left untreated, debilitating fears may linger throughout survivorship1,2 reducing quality of life (QoL).1,2,8,11,12”
From Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial. (2020) · cites this paper as [8]
In the citing paper
“Breast cancer survivors (BCS) are particularly vulnerable with up to 70% reporting clinically-significant FCR.”
From Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial. (2020) · cites this paper as [8]
In the citing paper
“All measures were validated, brief, and non-redundant, supporting parsimony while enabling comprehensive evaluation of intervention impact.”
In the citing paper
“On average, participants obtained a mean FCRI-T score of 68.9, and a score of 16.8 on the FCRI-S, which is above the clinical threshold (score of 13 or higher; 37).”
From Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study (2024) · cites this paper as [37]
In the citing paper
“clinical FCR is associated with impairment in functioning, psychological distress, sleep difficulties, stress response symptoms, and lower quality of life (QoL) [3–9].”
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Tabachnick, B. G., & Fidell, L. S. (1983) · Cited by 80,042
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
(2014) · Statistical Methods in Psychiatry Research and SPSS · doi:10.1201/b17560-26 · Cited by 12,056
Diagnostic and Statistical Manual of Mental Disorders(DSM)
(2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n182 · Cited by 10,830
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Statistical Package for the Social Sciences
Greatorex, M. (2015) · Wiley Encyclopedia of Management · doi:10.1002/9781118785317.weom090665 · Cited by 4,389
The kappa statistic in reliability studies: use, interpretation, and sample size requirements
Sim, J., & Wright, C. C. (2005) · Physical Therapy · doi:10.1093/ptj/85.3.257 · Cited by 4,093
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 5×
“This is consistent with previous FCR literature and supported the validity of the SIFCR [3, 5, 6].”
BackgroundResultSelf-citationStatistical Methods in Diagnostic Medicine
Zhou, X., Obuchowski, N. A., & McClish, D. K. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9780470317082 · Cited by 1,165
Simard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · cited 4×
“The nine-item FCRI-short form (FCRI-SF; [11]), which corresponds to the severity subscale of the FCRI, has a strong correlation with the total FCRI score (r=.”
BackgroundMethodInfluentialSelf-citationKoch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511 · cited 16×
“%) were considered as displaying clinical levels of FCR (i.e., SIFCR score ≥5).”
BackgroundResultInfluentialDeimling, G. T., Bowman, K. F., Sterns, S., Wagner, L. J., & Kahana, B. (2006) · Psycho-Oncology · doi:10.1002/pon.955 · Cited by 496
Vickberg, S. M. J. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2501_03 · Cited by 468
Structured Clinical Interview for DSM-IV (SCID)
Kübler, U. (2013) · Encyclopedia of Behavioral Medicine · doi:10.1007/978-1-4419-1005-9_66 · Cited by 442
Stark, D. P. H., & House, A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1405 · Cited by 431
Factors reported to influence fear of recurrence in cancer patients: a systematic review
Crist, J. V., & Grunfeld, E. A. (2013) · Psycho-Oncology · doi:10.1002/pon.3114 · Cited by 431
Adult cancer survivors: How are they faring?
Baker, F., Denniston, M., Smith, T., & West, M. M. (2005) · Cancer · doi:10.1002/cncr.21488 · Cited by 398
Murphy, J. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180068011 · Cited by 367 · cited 2×
“Conversely, specificity measures the degree to which an instrument accurately identifies patients in whom the condition or “disease” is not present [18].”
BackgroundROC Curves in Clinical Chemistry: Uses, Misuses, and Possible Solutions
Obuchowski, N. A., Lieber, M. L., & Wians, F. H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031823 · Cited by 358 · cited 1×
“Considering an equal number by group, a fair to moderate discriminant power of the FCRI-SF, a 5 % alpha error, and a power of 90 %, the required sample size was estimated from 28 to 66 participants [37].”
MethodFear of cancer progression and cancer‐related intrusive cognitions in breast cancer survivors
Mehnert, A., Berg, P., Henrich, G., & Herschbach, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1481 · Cited by 354
Fear of cancer recurrence: a systematic literature review of self‐report measures
Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, C. (2012) · Psycho-Oncology · doi:10.1002/pon.2070 · Cited by 262
Self-citationKoch, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Höpfner, S., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2014) · Psycho-Oncology · doi:10.1002/pon.3452 · Cited by 253
The Cancer Worry Scale: Detecting Fear of Recurrence in Breast Cancer Survivors
Custers, J. A. E., van den Berg, S. W., van Laarhoven, H. W. M., Bleiker, E. M. A., Gielissen, M. F. M., & Prins, J. B. (2014) · Cancer Nursing · doi:10.1097/ncc.0b013e3182813a17 · Cited by 243
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229 · cited 4×
“[25] showed that intrusive thoughts associated with FCR share many characteristics with worries.”
BackgroundMethodResultInfluentialSelf-citationThe diagnostic role of a short screening tool—the distress thermometer: a meta-analysis
Ma, X., Zhang, J., Zhong, W., Shu, C., Wang, F., Wen, J., Zhou, M., Sang, Y., Jiang, Y., & Liu, L. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2143-1 · Cited by 191
Fear of recurrence in long‐term testicular cancer survivors
Skaali, T., Fosså, S. D., Bremnes, R., Dahl, O., Haaland, C. F., Hauge, E. R., Klepp, O. N., Oldenburg, J., Wist, E., & Dahl, A. A. (2009) · Psycho-Oncology · doi:10.1002/pon.1437 · Cited by 180
Screening cancer patients' families with the distress thermometer (DT): a validation study
Zwahlen, D., Hagenbuch, N., Carley, M. I., Recklitis, C. J., & Buchi, S. (2008) · Psycho-Oncology · doi:10.1002/pon.1320 · Cited by 158
Roth, A., Nelson, C. J., Rosenfeld, B. D., Warshowski, A., O'Shea, N., Scher, H. I., Holland, J. C., Slovin, S. F., Curley, T., Reynolds, T. R., et al. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.4.340 · Cited by 158
Long-term adjustment of early-stage ovarian cancer survivors
Matulonis, U. A., Kornblith, A. B., Lee, H., Bryan, J., Gibson, C., Wells, C., Lee, J., Sullivan, L., & Penson, R. T. (2008) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01167.x · Cited by 158
Gil, K. M., Mishel, M. H., Belyea, M., Germino, B., Porter, L. S., Carlton LaNey, I., & Stewart, J. (2004) · Oncology Nursing Forum · doi:10.1188/04.onf.633-639 · Cited by 152
Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients
Humphris, G. M., Rogers, S., McNally, D., Lee-Jones, C., Brown, J., & Vaughan, D. (2003) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(03)90399-1 · Cited by 147
Comparison of the quality of life of early and advanced stage ovarian cancer survivors
Mirabeau-Beale, K. L., Kornblith, A. B., Penson, R. T., Lee, H., Goodman, A., Campos, S. M., Duska, L., Pereira, L., Bryan, J., & Matulonis, U. A. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.009 · Cited by 136
Hart, S. L., Latini, D. M., Cowan, J. E., Carroll, P. R., & CaPSURE™ Investigators (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0296-x · Cited by 132
Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress.
Mast, M. E. (1998) · PubMed · Cited by 124
members of the Conquer Fear Authorship Group, Butow, P. N., Bell, M. L., Smith, A. B., Fardell, J. E., Thewes, B., Turner, J., Gilchrist, J., Beith, J., Girgis, A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-201 · Cited by 117 · cited 1×
“These findings suggest that theoretical models of anxiety, particularly health anxiety, could be useful to gather a better understanding of FCR and guide treatment development [43].”
BackgroundLiu, Y., Pérez, M., Schootman, M., Aft, R. L., Gillanders, W. E., & Jeffe, D. B. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1551-x · Cited by 114
Thewes, B., Zachariae, R. H., Christensen, S., Nielsen, T., & Butow, P. N. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0383-1 · Cited by 94
Evidence-based assessment of anxiety disorders in adults.
Antony, M. M., & Rowa, K. (2005) · Psychological Assessment · doi:10.1037/1040-3590.17.3.256 · Cited by 83
Thewes, B., Bell, M. L., Butow, P., Beith, J., Boyle, F., Friedlander, M., McLachlan, S. A., & the Members of the FCR Study Advisory Committee (2013) · Psycho-Oncology · doi:10.1002/pon.3348 · Cited by 83
An Examination of the “Gold Standard” Diagnosis of Major Depression in Aged-Care Settings
Davison, T. E., McCabe, M. P., & Mellor, D. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318190b901 · Cited by 67 · cited 1×
“This strategy was largely used to validate self-report tools in anxiety disorders and depression [14, 16].”
Method[Use of ROC analysis in psychiatry].
Fombonne, E. J., & Fuhrer, R. (1994) · PubMed · Cited by 6
Lee-Jones, C., Humphris, G., Dixon, R., & Bebbington Hatcher, M. (1997) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199706)6:2 · Cited by 1
Research works printed but not linked: 1
- Fombonne E, Fuhrer R. L’application de l’analyse ROC en psychiatrie. Encéphale. 1995;18:545–50.
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
“Other cancer types 115 (27) 43 (10) 138 (32) 133 (31) 111 (29) 55 (14) 100 (26) 114 (30)”
Self-citationSimonelli, L. E., Siegel, S. D., & Duffy, N. M. (2017) · Psycho-Oncology · doi:10.1002/pon.4168 · Cited by 292
“The nine-item FCRI severity subscale has demonstrated psychometric properties [7] and established sensitivity and specificity for a cutoff score of 13 [8].”
Butow, P. N., Turner, J., Gilchrist, J., Sharpe, L., Smith, A. B., Fardell, J. E., Tesson, S., O’Connell, R., Girgis, A., Gebski, V. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.1257 · Cited by 228
Vaz-Luis, I., Masiero, M., Cavaletti, G., Cervantes, A., Chlebowski, R. T., Curigliano, G., Felip, E., Ferreira, A. R., Ganz, P. A., Hegarty, J., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.1941 · Cited by 208
Lebel, S., Mutsaers, B., Tomei, C., Leclair, C. S., Jones, G., Petricone-Westwood, D., Rutkowski, N., Ta, V., Trudel, G., Laflamme, S. Z., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234124 · Cited by 203
“Disease (k) Mode of determination (k) Range of prevalence Author Reported prevalence Determination of prevalence scores Cancer (58) 0–86 Cut-off (20) 4.3–70 Aghdam et al., 2014 [31] 49.6 Scale literature on FoP-Q-SF for “high FoP” Anderson et al., 2014 [134] 8 Scale literature cut-off for MAX-PC for “clinical fear of…”
BackgroundInfluential
Metadata
- Authors
- Simard, S., & Savard, J.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Université Laval (CA)
- Corresponding author
- Simard, Sébastien
- Venue
- Journal of Cancer Survivorship
- Published
- 2015-01-21
- Volume
- 9
- Issue
- 3
- Pages
- 481-491
- ISSN
- 1932-2259 (ISSN-L)
- 1932-2267
- OpenAlex
- W1991276220
- Cited by
- 329
- References
- 46
- Citations by year
- 2026: 24 · 2025: 45 · 2024: 41 · 2023: 38 · 2022: 43 · 2021: 31 · 2020: 18 · 2019: 33 · 2018: 17 · 2017: 18 · 2016: 14 · 2015: 6
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Cancer Survivorship (publishedVersion)
- PubMed (publishedVersion)
- Constellation (Université du Québec à Chicoutimi) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of cancer recurrence, cancer survivors, screening cut-off values, psychiatric comorbidity, anxiety disorders, breast cancer, prostate cancer, lung cancer, colorectal cancer, psychological distress
- MeSH terms
- Fear, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Comorbidity, Survivors, Disease Progression, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.